W J Mogabgab. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acute DiseaseAdolescentAdultAgedBronchitis/drug therapyCephalexin/adverse effectsCephalexin/therapeutic useCephalosporins/therapeutic useCephradine/adverse effectsCephradine/therapeutic useChildClinical Trials as TopicDrug EvaluationFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPharyngitis/drug therapyPneumococcal Infections/drug therapyPneumonia/drug therapyRespiratory Tract Infections/drug therapyStreptococcal Infections/drug therapyStreptococcus pneumoniae/isolation & purificationStreptococcus pyogenes/isolation & purificationUrinary Tract Infections/drug therapy
Substances： See more » CephalosporinsCephradineCephalexin
Year: 1976 PMID： 4284
Source DB: PubMed Journal: Curr Ther Res Clin Exp ISSN： 0011-393X